Harvard Apparatus Regenerative Technology, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Harvard Apparatus Regenerative Technology, Inc. (HRGN) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $2.52 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.52M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.81M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.50M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.57M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $2.52M 10-K · filed 2026-03-19 |
| 2024-12-31 | $2.81M 10-K · filed 2026-03-19 |
| 2023-12-31 | $2.50M 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.57M 10-K · filed 2024-03-28 |
| 2021-12-31 | $1.28M 10-K · filed 2023-03-30 |
| 2020-12-31 | $1.08M 10-K · filed 2022-03-31 |
| 2019-12-31 | $1.05M 10-K · filed 2021-04-13 |
| 2018-12-31 | $696.00K 10-K · filed 2020-03-27 |
| 2017-12-31 | $2.02M 10-K · filed 2019-03-29 |
| 2016-12-31 | $2.68M 10-K · filed 2018-04-03 |
| 2015-12-31 | $2.46M 10-K · filed 2017-03-17 |
| 2014-12-31 | $1.09M 10-K · filed 2016-03-30 |
| 2013-12-31 | $294.00K 10-K · filed 2015-03-27 |
| 2012-12-31 | $209.00K 10-K · filed 2014-03-31 |